The role of the immune system in aging: Mechanisms and implications for health

The immune system plays a crucial role in the aging process, influencing both the onset and progression of age-related diseases. As individuals age, the immune system undergoes significant changes, a phenomenon known as immunosenescence. This involves a decline in immune function characterized by reduced efficacy of immune responses, increased susceptibility to infections, and a higher incidence of chronic inflammatory conditions. Key aspects of immunosenescence include diminished production and function of lymphocytes, such as T and B cells, altered cytokine profiles, and an increase in systemic inflammation often referred to as "inflammaging." These changes contribute to a compromised ability to mount effective responses to pathogens and an increased risk of autoimmune diseases and cancer. Recent research has focused on understanding the molecular and cellular mechanisms underlying these age-related immune changes, including alterations in signal transduction pathways, mitochondrial dysfunction, and changes in the microbiome. Additionally, interventions aimed at rejuvenating the immune system, such as vaccination strategies, immunomodulatory therapies, and lifestyle modifications, are being explored to mitigate the impacts of immunosenescence. Advancing our understanding of the role of the immune system in aging holds promise for improving health outcomes and quality of life in the elderly population.

Illustrations explain the paper; they do not show study data.

AI-generated illustration

↗ Enlarge

The Circadian Feedback LoopClose ×

AI-generated conceptual illustration (human cellular nucleus and cytoplasm). It explains the idea and does not show study data.

Open full-size image ↗

Introduction

Circadian rhythms are intrinsic 24-hour cycles that regulate various physiological processes in organisms, ranging from sleep-wake cycles to metabolic and immune functions. These rhythms are driven by molecular clocks located in almost every cell of the body, and they are synchronized by a central clock in the Suprachiasmatic Nucleus (SCN) of the hypothalamus. The circadian system plays a crucial role in maintaining homeostasis, and disruptions to these rhythms are associated with a wide range of health disorders, including metabolic diseases, cancer, and neurodegenerative conditions. In recent years, significant advances have been made in understanding the molecular mechanisms of circadian rhythms and their health implications. This review will explore these advances, highlighting the core molecular components of the circadian clock, the regulatory pathways that control them, and the potential clinical implications of circadian disruption.

The molecular components of the circadian clock

The circadian clock consists of a core set of genes and proteins that generate and regulate rhythmic oscillations. At the heart of this clock are transcription-translation feedback loops (TTFLs) that form the molecular basis for circadian rhythms. The main components of these loops include CLOCK (Circadian Locomotor Output Cycles Kaput) and BMAL1 (Brain and Muscle ARNT-Like 1), which act as positive regulators, and PER (Period) and CRY (Cryptochrome) proteins, which serve as negative regulators.

CLOCK and BMAL1

The CLOCK and BMAL1 proteins form a heterodimer that binds to E-box elements on the promoters of target genes, initiating the transcription of PER, CRY, and other clock-controlled genes. This transcriptional activation peaks during the early part of the day, initiating the circadian cycle. CLOCK and BMAL1 are crucial for maintaining the overall rhythmicity of the clock, and mutations in either gene can lead to severe disruptions in circadian rhythms, such as sleep disorders and metabolic dysregulation (Partch et al., 2014) [9] .

PER and CRY

PER and CRY proteins accumulate in the cytoplasm as a result of the transcriptional activation by CLOCK and BMAL1. As their levels increase, PER and CRY translocate back into the nucleus, where they inhibit the activity of the CLOCK-BMAL1 complex, thereby repressing their own transcription. This repression constitutes the negative feedback loop that generates the circadian rhythm. The degradation of PER and CRY, regulated by kinases such as Casein Kinase 1 (CK1), allows the clock to reset and begin a new cycle (Zhang et al., 2013) [14] .

Additional regulators

Several other proteins and pathways are involved in finetuning the circadian clock. For example, REV-ERBα and RORα are nuclear receptors that regulate the expression of BMAL1. SIRT1, an NAD+-dependent deacetylase, modulates the acetylation status of CLOCK and other clock components, linking circadian rhythms to cellular metabolism and aging (Nakahata et al., 2008) [8] . These auxiliary components allow the clock to adapt to environmental cues, such as light and feeding cycles.

Regulatory mechanisms of circadian rhythms

While the core molecular clock generates circadian rhythms, these rhythms must be synchronized with external environmental cues, or zeitgebers, to maintain proper physiological function. The primary zeitgeber for circadian rhythms is light, but other cues, such as food intake and temperature, also play significant roles.

Light and the Suprachiasmatic Nucleus (SCN)

Light is the most potent environmental cue for synchronizing the circadian clock. In mammals, light is detected by intrinsically photosensitive retinal ganglion cells (ipRGCs) in the eye, which send signals to the SCN. The SCN, in turn, synchronizes peripheral clocks throughout the body via neural and hormonal signals. The primary output from the SCN is the hormone melatonin, produced by the pineal gland. Melatonin levels rise during the evening and are suppressed by light exposure, helping to regulate the sleep-wake cycle (Golombek & Rosenstein, 2010 & Krishna, 2023) [4,15] .

Feeding and the peripheral clocks

Feeding cycles are another important cue for circadian rhythms, particularly for peripheral clocks located in tissues such as the liver, adipose tissue, and muscles. Unlike the SCN, which is primarily entrained by light, these peripheral clocks are highly sensitive to the timing of food intake. Disruption of feeding patterns, such as eating late at night or during irregular hours, can desynchronize peripheral clocks from the central clock, leading to metabolic disturbances such as obesity, insulin resistance, and type 2 diabetes (Sahar & Sassone-Corsi, 2009) [10] .

Health implications of circadian disruption

Disruptions to the circadian system, whether through genetic mutations, environmental factors, or lifestyle choices, have significant consequences for health. Research over the past two decades has highlighted the connections between circadian disruption and various diseases, including metabolic disorders, cancer, and neurodegenerative diseases.

Circadian rhythms and metabolic health

The circadian clock regulates key metabolic processes, including glucose metabolism, lipid metabolism, and energy expenditure. Disruptions to the circadian system can lead to metabolic syndrome, a cluster of conditions that increase the risk of cardiovascular disease and diabetes. For example, shift work, which involves irregular light-dark and feeding cycles, has been linked to increased rates of obesity and insulin resistance (Wang et al., 2011) [13] . Animal studies have shown that disruption of the core clock genes, such as CLOCK and BMAL1, leads to dysregulated glucose metabolism and obesity, further emphasizing the role of circadian rhythms in maintaining metabolic health (Bass & Takahashi, 2010) [1] . Circadian regulation of metabolism is mediated through the control of enzymes involved in glucose and lipid processing, such as phosphoenolpyruvate carboxykinase (PEPCK), which is involved in gluconeogenesis. The timing of food intake is also crucial, as feeding during the inactive phase (night for humans) can lead to impaired metabolic function and weight gain.

Circadian disruption and cancer

Circadian rhythms regulate cell cycle progression and DNA repair mechanisms, both of which are critical for preventing cancer. Circadian disruption has been associated with an increased risk of cancer, particularly in individuals who engage in long-term shift work. Studies have shown that mutations in circadian clock genes, such as PER2, can lead to increased cancer susceptibility, as the loss of circadian control over cell division and DNA repair increases the likelihood of genetic mutations and tumor formation (Fu & Lee, 2003) [3] . Melatonin, which is produced in response to the SCN, has been shown to have anti-cancer properties, in part due to its ability to regulate the expression of tumor-suppressor genes and reduce oxidative stress. Chronic suppression of melatonin due to light exposure at night has been linked to an increased risk of breast and prostate cancers (Schernhammer et al., 2001) [11] .

Circadian rhythms and neurodegenerative diseases

The circadian system also plays a critical role in brain health, and disruptions to circadian rhythms have been implicated in neurodegenerative diseases such as Alzheimer's Disease (AD) and Parkinson's Disease (PD). Circadian dysfunction is commonly observed in patients with these conditions, manifesting as sleep disturbances, altered activity rhythms, and changes in cognitive function. Research suggests that the buildup of Amyloid-Beta (Aβ) plaques, a hallmark of AD, is regulated by the circadian clock. Studies in animal models have shown that circadian disruption accelerates the deposition of Aβ plaques, possibly due to impaired clearance of Aβ during sleep (Musiek et al., 2015) [7] . Similarly, circadian regulation of dopamine signaling has been linked to the pathophysiology of PD, with disruptions in dopamine rhythms contributing to motor and non-motor symptoms of the disease (Hood & Amir, 2017) [5] .

Advances in circadian rhythm research and therapeutic applications

Recent advances in circadian rhythm research have led to the development of novel therapeutic approaches aimed at mitigating the effects of circadian disruption. These include chronotherapy, light therapy, and pharmacological interventions targeting circadian pathways.

Chronotherapy

Chronotherapy involves the timing of medical treatments to align with the body's circadian rhythms, thereby optimizing efficacy and minimizing side effects. For example, the effectiveness of certain cancer therapies, such as chemotherapy, has been shown to vary depending on the time of day they are administered, as the circadian clock regulates cell cycle progression and DNA repair. By administering treatments during periods of maximal susceptibility of cancer cells, chronotherapy can improve patient outcomes and reduce toxicity (Lévi et al., 2010) [6] .

Light therapy

Light therapy is a used treatment for circadian rhythm disorders, such as seasonal affective disorder (SAD) and shift work disorder. Exposure to bright light, particularly blue-enriched light, during the morning can help reset the circadian clock and alleviate symptoms of depression and sleep disturbances. Recent studies have also explored the use of melanopsin-based light therapy, which targets ipRGCs in the retina to more effectively entrain the circadian clock (Berson et al., 2002) [2] .

Pharmacological interventions

Pharmacological targeting of circadian pathways is an emerging area of research, with potential applications in the treatment of metabolic disorders, cancer, and neurodegenerative diseases. Melatonin supplements are already widely used to treat circadian rhythm disorders, and newer compounds, such as REV-ERB agonists, are being developed to modulate the activity of circadian clock components. These drugs have shown promise in preclinical models of obesity, type 2 diabetes, and cancer by restoring circadian rhythmicity and improving metabolic and immune function (Solt et al., 2012) [12] .

Conclusion

Circadian rhythms are fundamental to the regulation of physiological processes, and disruptions to the circadian system have profound effects on health. Advances in molecular circadian research have provided critical insights into the mechanisms that govern circadian rhythms and their links to diseases such as cancer, metabolic disorders, and neurodegenerative diseases. Therapeutic approaches targeting the circadian clock, including chronotherapy, light therapy, and pharmacological interventions, hold promise for improving health outcomes and reducing the burden of circadian-related disorders.

1. Bass J, Takahashi JS. Circadian integration of metabolism and energetics. Science. 2010;330(6009):1349-1354.
2. Berson DM, Dunn FA, Takao M. Phototransduction by retinal ganglion cells that set the circadian clock. Science. 2002;295(5557):1070-1073.
3. Fu L, Lee CC. The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer. 2003;3(5):350361.
4. Golombek DA, Rosenstein RE. Physiology of circadian entrainment. Physiol Rev. 2010;90(3):1063-1102.
5. Hood S, Amir S. The aging clock: circadian rhythms and later life. J Clin Invest. 2017;127(2):437-446.
6. Lévi F, Okyar A, Dulong S, Innominato PF, Clairambault J. Circadian timing in cancer treatments. Annu Rev Pharmacol Toxicol. 2010;50:377-421.
7. Musiek ES, Xiong DD, Holtzman DM. Sleep, circadian rhythms, and the pathogenesis of Alzheimer disease. Exp Mol Med. 2015;47(3):e148.
8. Nakahata Y, Sahar S, Astarita G, Kaluzova M, SassoneCorsi P. Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1. Science. 2008;324(5927):654-657.
9. Partch CL, Green CB, Takahashi JS. Molecular architecture of the mammalian circadian clock. Trends Cell Biol. 2014;24(2):90-99.
10. Sahar S, Sassone-Corsi P. Metabolism and cancer: the circadian clock connection. Nat Rev Cancer. 2009;9(12):886-896.
11. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, et al. Rotating night shifts and risk of breast cancer in women participating in the Nurses' Health Study. J Natl Cancer Inst. 2001;93(20):1563-1568.
12. Solt LA, Wang Y, Banerjee S, Hughes T, Kojetin DJ, Lundasen T, et al. Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists. Nature. 2012;485(7396):62-68.
13. Wang XS, Armstrong ME, Cairns BJ, Key TJ, Travis RC. Shift work and chronic disease: the epidemiological evidence. Occup Med (Lond). 2011;61(2):78-89.
14. Zhang Y, Fang B, Emmett MJ, Damle M, Sun Z, Feng D, et al. Discrete functions of nuclear receptor Reverbα couple metabolism to the clock. Science. 2013;348(6242):1488-1492.
15. Krishna RH, Swamy AVVS. Review on the study of potential health hazards caused by blue light due to Melanopsin activity. Int J Adv Chem Res. 2023;5(1):85-88.